Lipoxin A(4) Attenuates Cell Invasion by Inhibiting ROS/ERK/MMP Pathway in Pancreatic Cancer

Lipoxin A(4) (LXA(4)), an endogenous arachidonic acid metabolite, was previously considered an anti-inflammatory lipid mediator. But it also has the potential to inhibit cancer progression. To explore the therapeutic effect of LXA(4) in pancreatic cancer, we used Panc-1 cells to investigate the mech...

Descripción completa

Detalles Bibliográficos
Autores principales: Zong, Liang, Li, Jiahui, Chen, Xin, Chen, Ke, Li, Wei, Li, Xuqi, Zhang, Lun, Duan, Wanxing, Lei, Jianjun, Xu, Qinhong, Shan, Tao, Ma, Qingyong, Sun, Hao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4663743/
https://www.ncbi.nlm.nih.gov/pubmed/26649143
http://dx.doi.org/10.1155/2016/6815727

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4663743/
https://www.ncbi.nlm.nih.gov/pubmed/26649143
http://dx.doi.org/10.1155/2016/6815727

Ejemplares similares